background
pneumonia
lead
caus
death
among
children
younger
year
studi
estim
caus
pneumonia
young
african
asian
children
use
novel
analyt
method
appli
clinic
microbiolog
find
multisit
intern
casecontrol
studi
nine
studi
site
seven
countri
bangladesh
gambia
kenya
mali
south
africa
thailand
zambia
site
enrol
studi
month
case
children
age
month
admit
hospit
sever
pneumonia
control
agegroupmatch
children
randomli
select
commun
surround
studi
site
nasopharyng
oropharyng
npop
urin
blood
induc
sputum
lung
aspir
pleural
fluid
gastric
aspir
test
cultur
multiplex
pcr
primari
analys
restrict
case
without
hiv
infect
abnorm
chest
xray
control
without
hiv
infect
appli
bayesian
partial
latent
class
analysi
estim
probabl
aetiolog
agent
individu
popul
level
incorpor
case
control
data
find
aug
jan
enrol
case
commun
control
primari
analysi
group
compris
case
without
hiv
infect
posit
chest
xray
commun
control
without
hiv
infect
wheez
present
case
rang
site
casefat
ratio
case
blood
cultur
posit
case
streptococcu
pneumonia
common
bacteria
isol
mycobacterium
tuberculosi
virus
less
common
cri
vs
bacteria
common
vs
sever
pneumonia
case
sever
case
rsv
greatest
aetiolog
fraction
cri
pathogen
human
rhinoviru
human
metapneumoviru
b
human
parainfluenza
viru
pneumonia
tuberculosi
h
influenza
account
aetiolog
distribut
observ
differ
aetiolog
fraction
age
bordetella
pertussi
parainfluenza
type
parechovirusenteroviru
p
jirovecii
rsv
rhinoviru
staphylococcu
aureu
pneumonia
differ
sever
rsv
aureu
pneumonia
parainfluenza
type
lead
ten
pathogen
site
account
site
aetiolog
fraction
interpret
studi
small
set
pathogen
account
case
pneumonia
requir
hospit
admiss
prevent
treat
subset
pathogen
could
substanti
affect
childhood
pneumonia
outcom
pneumonia
remain
greatest
caus
death
global
children
younger
year
account
estim
annual
death
beyond
neonat
period
substanti
reduct
past
decad
estim
pneumonia
death
million
vs
million
death
reflect
econom
develop
improv
nutrit
reduc
hous
hold
crowd
also
use
pneumoniaspecif
intervent
improv
case
managementinclud
empir
antibiot
treatmentand
effect
vaccin
lead
pneumonia
pathogen
despit
advanc
continu
progress
reduc
pneumonia
mortal
constrain
absenc
vaccin
remain
common
pathogen
pneumonia
etiolog
research
child
health
perch
studi
sought
characteris
caus
sever
childhood
pneumonia
requir
hospit
admiss
among
children
live
highburden
lowresourc
region
era
routin
use
vaccin
pertussi
select
pneumococc
serotyp
haemophilu
influenza
type
b
hib
measl
perch
studi
sought
provid
rigor
data
would
inform
futur
prevent
treatment
strategi
lowincom
lowermiddleincom
set
address
challeng
face
previou
pneumonia
aetiolog
studi
imperfect
standardis
method
analys
narrow
generalis
absenc
analyt
method
provid
primari
output
interest
aetiolog
distribut
report
descript
clinic
micro
bi
logic
find
perch
studi
use
tradit
analyt
approach
result
compar
pneumonia
studi
acknowledg
aetiolog
infer
result
alon
also
develop
new
analyt
approach
assess
aetiolog
distribut
pneumonia
approach
integr
microbiolog
result
multipl
specimen
type
multipl
result
one
pathogen
individu
approach
also
account
sensit
specif
individu
diagnost
test
use
report
probabl
distribut
microbi
aetiolog
studi
popul
individu
case
perch
casecontrol
studi
design
previous
describ
briefli
assess
caus
defin
sever
sever
pneumonia
definit
origin
present
among
children
age
month
present
admit
hospit
condit
nine
studi
locat
seven
countri
bass
gambia
bamako
mali
lusaka
zambia
soweto
south
africa
kilifi
kenya
dhaka
matlab
bangladesh
nakhon
phanom
sa
kaeo
evid
studi
design
perch
studi
detail
review
assess
bodi
evid
pneumonia
aetiolog
epidemiolog
laboratori
analyt
method
use
quantifi
caus
pneumonia
young
children
addit
establish
expert
panel
pneumonia
method
work
group
pmwg
provid
addit
advic
key
epidemiolog
laboratori
studi
design
analyt
issu
perch
studi
need
optimis
search
date
databas
use
search
term
restrict
detail
separ
public
zunera
gilani
colleagu
result
review
preexist
evid
decis
reach
pmwg
publish
set
method
paper
protocol
sinc
review
descript
result
three
larg
paediatr
pneumonia
aetiolog
studi
children
younger
year
publishedfrom
usa
epic
south
africa
drakenstein
multicountri
studi
gabriel
consid
analysi
perch
studi
comprehens
systemat
multisit
studi
caus
sever
sever
pneumonia
hospit
admiss
among
children
age
month
context
routin
use
haemophilu
influenza
type
b
pneumococc
conjug
vaccin
emphasi
singl
protocol
highli
standardis
implement
qualiti
control
step
throughout
studi
conduct
inclus
divers
site
routin
implement
exist
pneumonia
vaccin
durat
enrol
captur
season
trend
use
multiplex
quantit
pcr
inclus
multipl
bodi
fluid
specimen
inclus
appropri
control
group
adjust
sensit
laboratori
test
larg
size
studi
provid
strength
inferenti
valu
result
studi
provid
result
pathogen
allow
crosssit
comparison
aetiolog
distribut
highli
standardis
methodolog
first
infecti
aetiolog
studi
integr
result
test
multipl
pathogen
multipl
bodi
fluid
specimen
use
rang
laboratori
assay
provid
aetiolog
distribut
pathogen
uncertainti
interv
individu
popul
result
show
ten
pathogen
respons
case
sever
pneumonia
requir
hospit
admiss
children
younger
year
across
wide
rang
geograph
epidemiolog
set
caus
pneumonia
vari
age
strata
sever
statu
lesser
degre
geographi
polici
perspect
low
number
pathogen
common
caus
pneumonia
requir
hospit
admiss
children
younger
year
across
site
could
allow
target
develop
pneumonia
intervent
respiratori
syncyti
viru
common
caus
diseas
primari
target
dedic
prevent
treatment
effort
especi
children
younger
month
bacteri
pathogen
cumul
caus
substanti
proport
diseas
treatabl
commonli
fatal
remain
target
earli
access
treatment
studi
clearli
show
inferenti
valu
nasopharyng
specimen
vari
pathogen
low
number
pathogen
provid
evid
causal
perch
integr
analysi
show
valu
analyt
approach
account
pathogen
preval
test
perform
multipl
specimen
multipl
result
individu
pathogen
method
develop
perch
studi
integr
data
principl
approach
offer
opportun
aetiolog
studi
also
adapt
use
method
thailand
select
repres
divers
epi
demiolog
condit
open
call
applic
site
characterist
vacci
nation
schedul
countri
screen
enrol
procedur
describ
appendix
site
except
thailand
routin
use
hib
vaccin
pneumococc
conjug
vaccin
pcv
routin
use
gambia
kenya
mali
south
africa
routin
use
zambia
last
month
perch
studi
influenza
vaccin
routin
use
site
case
enrol
time
present
hospit
sever
pneumonia
defin
cough
difficulti
breath
lower
chest
wall
indraw
sever
pneumonia
defin
cough
difficulti
breath
least
one
follow
sign
central
cyanosi
difficulti
breastfeed
drink
vomit
everyth
convuls
lethargi
unconsci
head
nod
elev
respiratori
rate
part
case
definit
appendix
exclus
criteria
case
control
hospitalis
within
preced
day
discharg
perch
case
within
preced
day
resid
outsid
studi
catchment
area
case
addit
exclus
criterion
resolut
lower
chest
wall
indraw
bronchodil
therapi
children
wheez
site
case
assess
occur
within
h
admiss
bangladesh
children
dhaka
site
met
case
definit
identifi
outpati
clinic
refer
hospit
admiss
children
whose
parent
refus
hospit
admiss
still
enrol
met
inclus
criteria
site
enrol
particip
period
appendix
case
screen
done
h
per
day
day
per
week
four
site
kilifi
sa
kaeo
nakhon
phanom
matlab
elig
consent
case
enrol
remain
site
screen
done
establish
hour
elig
consent
case
present
predefin
screen
hour
enrol
except
mali
systemat
sampl
process
use
appendix
control
randomli
select
resid
catchment
area
case
frequenc
match
case
age
group
month
month
month
month
age
previous
describ
site
aim
enrol
minimum
con
trol
monthli
match
case
count
enrol
case
month
control
enrol
regardless
respiratori
symptom
provid
least
bias
comparison
estim
pneumonia
caus
inelig
met
perch
case
definit
enrol
children
test
hiv
except
bangladesh
control
gambia
thailand
low
hivpreval
set
hiv
posit
control
oversampl
site
high
hiv
preval
zambia
south
africa
recruit
hiv
treatment
clinic
studi
protocol
approv
institut
review
board
ethic
review
committe
seven
institut
john
hopkin
school
public
health
parent
guardian
particip
provid
written
inform
consent
follow
stan
dardis
procedur
assess
enrol
criteria
clinic
assess
specimen
collect
data
collect
laboratori
test
studi
protocol
data
collect
form
standard
oper
procedur
clinic
train
video
publicli
avail
case
underw
clinic
examin
admiss
h
h
child
still
hospitalis
includ
assess
respiratori
sign
anthro
po
morphic
measur
peripher
oxygen
satur
room
air
whenev
possibl
assess
vital
statu
case
followup
visit
telephon
interview
done
day
admiss
window
day
control
similarli
assess
clinic
find
enrol
followup
assess
clinic
definit
use
analys
describ
appendix
enrol
collect
nasopharyng
oropharyng
npop
urin
blood
specimen
case
control
blood
cultur
induc
sputum
lung
aspir
pleural
fluid
gastric
aspir
case
result
bacteri
tuberculosi
cultur
blood
lung
aspir
pleural
fluid
immedi
avail
treat
physician
pcr
result
batch
avail
clinic
manag
chest
xray
obtain
case
enrol
interpret
two
member
perch
chest
radiograph
read
panel
train
method
discord
read
arbitr
describ
elsewher
reader
mask
site
clinic
factor
chest
xray
classifi
consoli
dation
infiltr
normal
uninterpret
standardis
criteria
defin
xray
abnorm
posit
chest
xray
show
either
consolid
infiltr
specimen
collect
procedur
laboratori
test
method
determin
pathogenspecif
pcr
densiti
threshold
use
analys
describ
separ
elsewher
appendix
briefli
use
multiplex
quantit
pcr
ftd
fast
track
diagnost
sliema
malta
cultur
test
npop
swab
case
control
cultur
done
streptococcu
pneumonia
alon
induc
sputum
case
lung
aspir
elig
case
gambia
bangladesh
mali
south
africa
pleural
fluid
discret
treat
paediatrician
case
pleural
effus
chest
xray
gastric
aspir
case
cultur
mycobacteria
alon
test
blood
sampl
pneumonia
pcr
case
control
cultur
case
pleural
fluid
specimen
signal
posit
see
onlin
appendix
studi
protocol
studi
materi
see
http
wwwjhspheduivacresourc
perchbackgroundandmethod
autom
cultur
yield
pathogen
subcultur
also
test
pneumococc
antigen
binaxnow
aler
orlando
fl
usa
appendix
test
serum
specimen
case
control
presenc
antimicrobi
activ
specimen
case
also
test
creactiv
protein
pathogen
detect
blood
cultur
except
contamin
includ
potenti
pathogen
exclud
pcr
result
klebsiella
pneumonia
poor
assay
specif
identifi
test
protocol
establish
moraxella
catarrhali
npop
pcr
result
describ
studi
exclud
integr
aetiolog
analysi
result
provid
use
diagnost
evid
control
preval
catarrhali
substanti
higher
case
preval
appendix
implement
confirmatori
uniplex
pcr
test
specimen
test
posit
multiplex
assay
legionella
spp
pertussi
hib
appendix
sever
pathogen
similar
preval
case
control
ie
pneumonia
h
influenza
cytomegaloviru
p
jirovecii
npop
specimen
pneumonia
whole
blood
specimen
posit
redefin
use
quantit
pcr
densiti
threshold
base
analys
remain
pathogen
standard
assay
threshold
use
blood
cultur
contamin
defin
standard
criteria
appendix
result
exclud
aetiolog
analysi
obtain
singl
induc
sputum
gastric
aspir
specimen
case
except
south
africa
two
specimen
routin
collect
increas
tuberculosi
detect
physician
discret
case
suspect
tuberculosi
diagnosi
first
specimen
alon
use
defin
posit
result
mycobacterium
tuberculosi
ensur
crosssit
compa
rabil
lower
sensit
singl
specimen
account
aetiolog
analysi
except
tuberculosi
use
induc
sputum
result
aetiolog
analysi
microbiolog
find
sputum
cultur
pcr
add
inform
beyond
ad
npop
specimen
analyt
advantag
avail
case
control
pneumococc
serotyp
assess
quellung
reaction
pcr
npop
specimen
cultur
neg
pcr
posit
met
densiti
threshold
criteria
posit
adequ
specimen
volum
use
microarray
assay
assess
serotyp
appendix
serotyp
group
vaccin
type
nonvaccin
type
accord
pcv
formul
gambia
mali
south
africa
zambia
part
studi
period
use
wherea
kenya
use
tenval
pcv
multiplex
pcr
panel
includ
target
h
influenza
h
influenza
type
b
cultur
isol
serotyp
slide
agglutin
pcr
npop
specimen
case
met
studi
defin
clinic
criteria
measl
test
measl
pcr
appendix
antibiot
exposur
time
specimen
collect
defin
either
document
admin
istrat
antibiot
facil
antibiot
activ
serum
measur
staphylococcu
aureu
bioassay
collect
time
specimen
data
singledata
enter
centralis
electron
data
captur
system
emm
corpor
rockvil
md
usa
kenya
site
extract
data
exist
electron
data
captur
system
conform
studi
data
entri
standard
number
site
number
particip
enrol
per
site
base
combin
feasibl
within
budget
case
preval
site
site
elig
includ
among
criteria
minimum
case
per
year
sever
pneumonia
requir
hospit
admiss
children
age
month
seven
site
select
result
would
repres
divers
epidemiolog
set
asia
africa
site
enrol
year
rather
year
enabl
ass
sment
season
annual
variat
outbreak
aetiolog
unless
otherwis
specifi
restrict
analys
case
control
without
hiv
infect
aetiolog
distribut
expect
vari
substanti
accord
hiv
infect
statu
report
separ
public
primari
analysi
esti
mate
aetiolog
fraction
sever
sever
pneumonia
among
case
posit
chest
xray
case
restrict
posit
result
chest
xray
analyt
method
assess
caus
perch
integr
analysi
pia
model
assum
case
lung
infect
secondari
analysi
case
without
hiv
infect
regardless
chest
xray
done
report
appendix
children
miss
laboratori
measur
use
integr
aetiolog
analysi
blood
cultur
npop
pcr
whole
blood
pcr
tuberculosi
cultur
case
npop
pcr
whole
blood
pcr
control
exclud
analys
children
least
one
measur
ment
miss
data
measur
imput
model
estim
use
standard
bayesian
method
statist
comparison
demograph
clinic
characterist
site
casecontrol
group
done
logist
regress
adjust
age
month
without
site
appropri
compar
preval
organ
measur
case
control
use
odd
ratio
or
ci
calcul
logist
regress
adjust
site
age
month
pathogen
detect
adjust
npop
pcr
result
alon
could
adjust
previou
antibiot
use
rare
among
control
except
select
sitestratifi
analys
result
site
combin
comprehens
sitespecif
result
publish
separ
use
elev
creactiv
protein
concentr
case
descript
analysi
variabl
pia
model
develop
use
pia
model
novel
applic
bayesian
latent
class
analysi
integr
case
control
data
across
multipl
specimen
test
result
estim
aetiolog
distribut
individu
case
popul
case
method
assum
infect
bodi
site
peripher
lung
indic
caus
put
lung
infect
measur
independ
one
anoth
method
test
use
simul
dataset
compris
case
known
aetiolog
mix
measur
vari
sensit
specif
prespecifi
shown
give
accur
estim
aetiolog
fraction
even
mild
violat
independ
assumpt
pia
model
use
markov
chain
mont
carlo
algorithm
con
vergenc
sampl
posterior
distribut
aetiolog
estim
given
observ
measur
appendix
populationlevel
estim
pathogen
averag
individu
case
probabl
credibl
interv
cri
bayesian
analogu
confid
interv
sensit
analys
done
assess
influenc
valu
use
aetiolog
sensit
prior
appendix
allow
possibl
pneumonia
event
caus
pathogen
test
includ
pathogen
categori
term
otherwis
specifi
no
case
neg
test
pathogen
posit
result
measur
poor
specif
higher
individuallevel
probabl
includ
no
categori
case
pia
model
assum
pneumonia
event
caus
singl
pathogen
case
multipl
pathogen
detect
silver
standard
measur
eg
blood
cultur
lung
aspir
pleural
fluid
model
distinguish
one
domin
caus
case
model
distribut
aetiolog
probabl
equal
across
pathogen
detect
distribut
lead
underestim
contri
bution
true
caus
diseas
sum
pathogen
probabl
individu
case
primari
pathogen
model
must
case
neg
silver
standard
measur
caus
distribut
across
multipl
pathogen
accord
strength
evid
pathogen
evid
includ
whether
pathogen
detect
multipl
sampl
individu
pathogen
preval
among
case
pathogen
odd
ratio
apriori
assumpt
regard
sensit
aetiolog
bayesian
analysi
assign
apriori
estim
aetiolog
distribut
sensit
laboratori
measur
estim
quantifi
preced
uncertainti
model
paramet
apriori
aetiolog
distribut
favour
pathogen
anoth
uninform
want
estim
caus
use
evid
perch
studi
alon
apriori
sensit
distribut
select
intern
work
group
use
avail
inform
extern
perch
studi
vari
laboratori
test
method
pathogen
tabl
appendix
classifi
specimen
accord
estim
measur
error
either
bronz
ie
imperfect
sensit
specif
silver
standard
ie
imperfect
sensit
specif
test
categoris
gold
standard
ie
sensit
specif
tabl
apriori
estim
measurementspecif
sensit
detail
appendix
background
inform
support
choic
sensit
prior
provid
appendix
base
prior
specimen
blood
cultur
volum
greater
ml
blood
cultur
evid
previou
antibiot
exposur
reduc
prior
specimen
blood
cultur
volum
lower
ml
evid
previou
antibiot
exposur
criteria
applic
pathogen
measur
detail
appendix
npopnasopharyng
oropharyng
nanot
applic
direct
evid
diagnost
sensit
blood
cultur
pneumonia
h
influenza
obtain
vaccin
probe
studi
pathogen
set
base
blood
cultur
sensit
prior
except
salmonella
spp
enterobacteriacea
n
meningitidi
select
wider
prior
reflect
greater
uncertainti
reduc
previou
antibiot
exposur
low
blood
volum
blood
cultur
see
appendix
detail
appendix
control
preval
lung
aspir
pleural
fluid
use
updat
aetiolog
prior
distribut
appli
case
similar
clinic
characterist
specimen
tuberculosi
cultur
induc
sputum
gastric
aspir
pcr
result
npop
swab
whole
blood
pneumonia
alon
specimen
includ
bronz
standard
measur
control
provid
data
estim
specif
reduc
sensit
detect
bacteri
pathogen
npop
pcr
pneumonia
h
influenza
blood
cultur
specimen
individu
whose
specimen
collect
document
antibiot
exposur
blood
cultur
specimen
low
blood
volum
appendix
pia
model
integr
apriori
distribut
observ
data
chang
updat
apriori
distribut
sensit
estim
contribut
studi
data
produc
aetiolog
estim
posit
lung
aspir
result
use
updat
apriori
aetiolog
distribut
case
similar
chest
xray
characterist
appendix
intrins
within
pia
model
sensit
bronz
standard
measur
eg
npop
individu
bacteria
updat
use
result
case
posit
blood
cultur
enrol
enrol
cap
mali
site
ten
polit
unrest
bangladesh
kenya
nine
zambia
reason
state
clinic
descript
analysi
aspir
pleural
fluid
specimen
collect
subset
case
elig
procedur
sampl
low
volum
cultur
done
test
done
subset
case
met
studi
defin
clinic
criteria
measl
laboratori
descript
analysi
aetiolog
analysi
least
one
follow
specimen
requir
child
includ
aetiolog
analysi
blood
cultur
npop
pcr
wb
pcr
tuberculosi
cultur
case
npop
pcr
wb
pcr
control
number
contact
screen
elig
includ
extrapol
data
zambia
south
africa
site
data
avail
month
zambia
month
south
africa
site
avail
data
use
extrapol
number
month
miss
data
assum
contact
particip
elig
rate
constant
time
shown
addit
control
hiv
infect
enrol
hiv
clinic
south
africa
zambia
site
ensur
adequ
sampl
size
children
hiv
infect
children
describ
forthcom
manuscript
devot
caus
sever
sever
pneumonia
children
hiv
infect
total
number
children
contact
number
children
declin
show
clinic
avail
mali
site
site
avail
data
total
number
children
contact
ie
site
except
mali
randomli
select
children
household
contact
number
children
guardian
contact
use
denomin
percentag
children
screen
elig
enrol
denomin
exclud
mali
numer
percentag
screen
elig
enrol
overestim
pia
model
appli
data
site
com
bine
assum
measur
sensi
tiviti
common
across
site
allow
aetio
logic
distribut
control
preval
vari
across
site
appendix
analys
stratifi
age
year
year
pneumonia
sever
sever
sever
allsit
result
base
case
posit
chest
xray
wherein
case
without
regard
site
contribut
equal
estim
aetiolog
distribut
base
control
assess
differ
aetiolog
distri
bution
relat
site
standardis
age
sever
case
distribut
site
site
combin
appendix
compar
age
severitystandardis
result
across
site
ten
focu
pathogen
h
influenza
tuberculosi
aureu
pneumonia
human
metapneumoviru
hmpv
influenza
parainfluenza
rhinoviru
respi
ratori
syncyti
viru
rsv
p
jirovecii
defin
focu
pathogen
basi
result
allsit
aetiolog
analysi
focu
pathogen
aetiolog
estim
higher
higher
epidemiolog
interest
defin
treatabl
antibiot
p
jirovecii
aureu
avail
vaccin
influenza
viru
cri
around
aetiolog
fraction
three
pathogen
overlap
nonfocu
pathogen
therefor
use
term
focu
pathogen
rather
label
ten
common
pathogen
studi
also
report
list
sitespecif
ten
common
pathogen
overal
aetiolog
fraction
pathogen
ie
ten
pathogen
highest
aetiolog
fraction
given
site
statist
analys
sa
version
bayesian
infer
softwar
jag
npop
pcr
figur
creat
r
version
pia
model
use
opensourc
r
softwar
packag
develop
call
bayesian
analysi
kit
etiolog
research
work
group
meet
inform
studi
design
role
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
aug
jan
enrol
elig
children
sever
sever
pneumonia
case
elig
children
studi
catchment
area
contact
commun
control
addit
con
trol
hiv
infect
enrol
hiv
clinic
south
africa
zambia
hivspecif
analys
report
separ
figur
enrol
case
control
vari
season
appendix
approxim
plan
specimen
rang
tabl
tabl
appendix
case
unevenli
distribut
across
seven
site
case
posit
chest
xray
thailand
made
lowest
percentag
wherea
south
africa
made
highest
appendix
seven
countri
everi
site
except
thailand
case
posit
xray
younger
month
major
younger
month
appendix
control
older
case
gambia
mali
south
africa
dhaka
bangladesh
site
p
appendix
proport
case
sever
pneumonia
lowest
bangladesh
gambia
highest
mali
kenya
p
tabl
appendix
case
fatal
ratio
case
posit
xray
case
vari
markedli
site
p
higher
case
sever
pneumonia
sever
case
without
hiv
infect
posit
xray
rang
site
case
sever
pneumonia
sever
case
without
hiv
infect
posit
xray
rang
site
appendix
clinic
characterist
admiss
case
posit
chest
xray
vari
substanti
site
tabl
appendix
particularli
wheez
rang
site
fever
hypoxaemia
oxygen
administr
p
note
south
african
site
altitud
sea
level
standard
clinic
practic
administ
supplement
oxygen
admiss
often
record
oxygen
satur
children
admit
hospit
diagnosi
sever
pneumonia
addit
mali
oxygen
administr
data
exclud
analysi
inadequ
standardis
data
record
tachypnoea
commonli
observ
site
case
malnutrit
defin
weightforag
z
score
lower
found
case
posit
xray
without
hiv
infect
signific
variabl
site
p
malnutrit
common
case
control
site
appendix
preval
south
africa
april
pcv
introduc
zambia
juli
lusaka
month
end
studi
enrol
durat
ill
defin
durat
day
cough
wheez
fever
difficulti
breath
whichev
longest
tachypnoea
defin
breath
per
min
month
breath
per
min
month
breath
per
min
month
hypoxaemia
defin
oxygen
satur
lower
site
elev
zambia
south
africa
supplement
oxygen
use
room
air
oxygen
satur
read
avail
room
air
oxygen
satur
read
avail
children
south
african
site
altitud
sea
level
standard
clinic
practic
administ
supplement
oxygen
children
admit
hospit
diagnosi
sever
pneumonia
elev
white
blood
cell
wbc
count
defin
greater
cell
per
l
children
age
month
greater
cell
per
l
children
age
month
crpcreactiv
protein
restrict
endem
site
kenya
gambia
mali
zambia
children
younger
year
full
vaccin
defin
receiv
least
one
dose
date
age
basi
child
age
enrol
dose
receiv
countri
schedul
allow
window
dose
children
age
year
older
full
vaccin
defin
receiv
three
dose
children
younger
year
full
vaccin
defin
receiv
least
one
dose
date
age
basi
child
age
enrol
dose
receiv
countri
schedul
allow
window
dose
children
age
year
older
site
except
kenya
full
vaccin
defin
receiv
three
dose
children
older
year
kenya
introduc
pcv
catchup
campaign
full
vaccin
defin
receiv
three
dose
two
dose
given
least
week
apart
child
older
year
age
first
dose
one
dose
child
older
year
dose
introduct
restrict
ageelig
least
one
dose
restrict
children
older
month
month
bangladesh
children
age
month
older
defin
serum
bioassay
posit
case
control
antibiot
administ
referr
facil
antibiot
administr
collect
whole
blood
specimen
studi
facil
case
restrict
children
blood
cultur
case
whole
blood
case
control
collect
data
record
mali
site
basi
time
present
time
admiss
done
site
mali
exclud
site
summari
case
blood
cultur
collect
miss
blood
cultur
volum
data
children
discharg
aliv
vital
statu
data
obtain
day
longer
admiss
previou
exposur
antibiot
vari
site
case
control
statu
coverag
vaccin
pertussi
hib
pneumonia
measl
appendix
p
enrol
case
vari
season
site
except
mali
zambia
appendix
blood
cultur
posit
pathogen
case
posit
chest
xray
avail
blood
cultur
percentag
rang
site
figur
appendix
isol
rate
vari
significantli
age
strata
vari
case
sever
lower
among
case
previou
antibiot
exposur
blood
volum
lower
ml
appendix
bacteri
speci
commonli
isol
blood
cultur
pneumonia
posit
blood
cultur
howev
pneumococc
isol
cultur
site
south
africa
thailand
bangladesh
although
part
core
method
south
africa
two
blood
cultur
flag
posit
test
posit
pneumococc
antigen
neg
pneumococc
cultur
appendix
tuberculosi
cultur
case
posit
xray
induc
sputum
one
gastric
aspir
appendix
lung
aspir
pleural
fluid
speci
men
test
cultur
pcr
posit
pathogen
bacteri
pathogen
often
pneumonia
lung
aspir
aureu
pleural
fluid
commonli
detect
case
viral
pathogen
three
case
viral
pathogen
codetect
bacteria
tabl
appendix
multipl
pathogen
observ
six
lung
aspir
yield
least
one
pathogen
cultur
pcr
none
ten
case
posit
chest
xray
met
clinic
screen
definit
measl
test
posit
measl
appendix
pneumonia
commonli
detect
control
case
posit
chest
xray
appli
pcr
densiti
threshold
best
distinguish
case
control
proport
posit
result
case
posit
xray
chang
pneumonia
h
influenza
p
jirovecii
cytomegalo
viru
chang
rank
order
commonli
detect
bacteria
npop
specimen
catarrhali
h
influenza
aureu
pneumonia
appendix
compar
control
posit
chest
xray
case
significantli
associ
presenc
differ
pathogen
npop
specimen
figur
adjust
or
npop
pcr
result
rang
wide
across
pathogen
rsv
ci
parainfluenza
human
meta
pneumoviru
b
highest
adjust
or
follow
influenza
bordetella
pertussi
parainfluenza
influenza
b
pertussi
infrequ
detect
case
figur
appendix
catarrhali
pathogen
significantli
neg
associ
case
statu
ci
observ
minor
chang
magnitud
direct
or
remov
adjust
detect
pathogen
appendix
whole
blood
pcr
posit
pneumonia
case
posit
xray
nearli
preval
control
ci
appli
pcr
densiti
threshold
log
copi
per
ml
enhanc
differ
entiat
case
control
preval
case
posit
chest
xray
versu
control
appendix
integr
microbiolog
result
multipl
specimen
among
case
posit
chest
xray
control
estim
diseas
due
viral
pathogen
cri
bacteri
pathogen
tuberculosi
remain
aetiolog
fraction
attribut
tuberculosi
candida
spp
p
jirovecii
caus
otherwis
specifi
figur
appendix
rsv
common
caus
cri
common
pathogen
account
aetiolog
distribut
includ
human
rhinoviru
hmpv
b
human
parainfluenza
viru
type
combin
pneumonia
tuberculosi
h
influenza
unknown
caus
no
categori
account
cri
pneumonia
aetiolog
distribut
fraction
pneumonia
attribut
pathogen
target
current
licens
vaccin
hib
vaccineserotyp
pneumonia
pertussi
tuberculosi
influenza
b
age
month
pathogen
differ
aetiolog
fraction
age
strata
b
pertussi
parainfluenza
type
aureu
p
jirovecii
rsv
greater
aetiolog
fraction
children
younger
year
age
year
older
wherea
parechovirusenteroviru
parainfluenza
type
rhinoviru
pneumonia
common
caus
children
age
year
older
younger
year
figur
appendix
found
seven
pathogen
top
ten
pathogen
age
strata
rsv
rhinoviru
hmpv
parainfluenza
pneumonia
tuberculosi
h
influenza
aetiolog
distribut
finer
age
strata
provid
appendix
observ
differ
aetiolog
fraction
pneumonia
sever
rsv
aureu
pneumonia
parainfluenza
type
viral
caus
combin
figur
appendix
analys
case
regardless
chest
xray
find
compar
case
posit
xray
greater
aetiolog
fraction
attribut
rhinoviru
case
vs
case
posit
xray
parechovirusenteroviru
vs
nonfer
gramneg
bacteria
vs
case
otherwis
analys
differ
substant
appendix
aetiolog
chest
xray
find
ing
report
separ
manuscript
sitespecif
aetiolog
result
standardis
age
sever
ten
focu
pathogen
show
consist
across
site
pathogen
figur
appendix
includ
influenza
exceed
site
except
zambia
except
consist
includ
follow
rhinoviru
sub
stantial
common
bangladesh
kenya
h
influenza
extrem
uncommon
bangladesh
h
influenza
type
b
zambia
mali
nontyp
b
h
influenza
south
africa
dispro
portion
higher
site
pneumonia
vaccinetyp
nonvaccinetyp
higher
gambia
mali
site
fraction
case
attribut
bacteria
lower
bangladesh
kenya
site
rang
tuberculosi
larger
aetiolog
fraction
zambia
gambia
thailand
south
africa
site
no
contribut
less
site
except
thailand
result
stan
dardis
age
sever
appendix
differ
primari
non
standardis
sitespecif
result
ie
base
mix
case
enrol
site
cumul
aetiolog
fraction
standardis
sitespecif
ten
common
pathogen
account
aetiolog
fraction
everi
site
figur
contrast
cumul
aetiolog
fraction
ten
focu
pathogen
rang
site
reflect
heterogen
across
site
rank
order
pathogen
appendix
distribut
individu
case
aetiolog
probabl
children
younger
year
full
vaccin
defin
receiv
least
one
dose
date
age
basi
child
age
enrol
dose
receiv
countri
schedul
allow
window
dose
children
age
year
older
full
vaccin
defin
receiv
three
dose
children
younger
year
full
vaccin
defin
receiv
least
one
dose
date
age
basi
child
age
enrol
dose
receiv
countri
schedul
allow
window
dose
children
age
year
older
site
except
kenya
full
vaccin
defin
receiv
three
dose
children
older
year
kenya
introduc
pcv
catchup
campaign
full
vaccin
defin
receiv
three
dose
two
dose
given
least
week
apart
child
older
year
age
first
dose
one
dose
child
older
year
dose
introduct
restrict
ageelig
least
one
dose
restrict
children
older
month
month
bangladesh
children
age
month
older
defin
serum
bioassay
posit
case
control
antibiot
administ
referr
facil
antibiot
administr
collect
whole
blood
specimen
studi
facil
case
restrict
children
blood
cultur
case
whole
blood
case
control
collect
data
record
mali
site
basi
time
present
time
admiss
done
site
gambia
basi
evid
concurr
project
clinic
care
children
receiv
oxygen
hypoxaemia
code
studi
case
blood
cultur
collect
miss
blood
cultur
volum
data
bangladesh
thailand
kenya
zambia
mali
gambia
south
africa
children
discharg
aliv
vital
statu
data
obtain
day
longer
admiss
pathogen
casespecif
lead
pathogen
viru
site
provid
appendix
sensit
analys
done
assess
effect
assumpt
pia
model
sensit
aetiolog
prior
aetiolog
find
lower
narrow
pneumococc
blood
cultur
sensit
prior
increas
aetiolog
prior
littl
effect
pneumonia
aetiolog
estim
probabl
strength
evid
regard
pneumonia
measur
npop
pcr
whole
blood
pcr
appendix
increas
aetiolog
prior
no
base
case
result
increas
no
aetiolog
estim
lower
site
across
site
appendix
princip
find
perch
studi
lowincom
lowmiddleincom
set
wide
spread
uptak
hib
vaccin
pcv
virus
especi
rsv
predomin
caus
pneu
monia
requir
hospit
admiss
children
younger
year
site
bacteria
continu
caus
quarter
third
case
site
small
number
pathogen
account
case
admit
hospit
radiograph
confirm
pneumonia
ten
common
pathogen
given
site
account
case
diseas
site
furthermor
case
everi
site
caus
hand
pathogen
commonli
found
site
nonetheless
rel
contribut
pathogen
vari
age
lesser
degre
sever
diseas
approxim
half
children
admit
hospit
defin
sever
sever
pneumonia
infiltr
chest
xray
among
case
clinic
characterist
vari
substanti
across
site
includ
case
sever
present
presenc
wheez
casefat
ratio
nevertheless
found
littl
variabl
pathogen
commonli
detect
bodi
fluid
specimen
case
across
studi
site
except
low
recoveri
bacteria
blood
specimen
asian
site
pathogen
account
major
aetiolog
distribut
rsv
domin
pathogen
site
account
aetiolog
distribut
three
time
greater
next
lead
pathogen
rsv
notabl
frequent
detect
npop
case
posit
chest
xray
also
uncommon
detect
control
make
one
pathogen
includ
parainfluenza
hmpv
detect
high
predict
valu
aetiolog
attribut
rsv
common
pathogen
across
age
strata
pneumonia
sever
although
aetiolog
fraction
notabl
higher
infant
older
children
predomin
rsv
emphasis
import
prevent
therapeut
target
past
decad
pneumonia
aetiolog
studi
usa
south
africa
gabriel
multisit
studi
also
identifi
rsv
import
target
contribut
parainfluenza
virus
hmpv
aetiolog
distribut
vari
littl
age
strata
diseas
sever
vari
site
record
low
preval
influenza
b
site
aetiolog
contribut
influenza
b
exceed
site
except
zambia
influenza
circul
vari
annual
year
enrol
perch
studi
might
low
circul
year
test
pathogen
human
rhinoviru
associ
geograph
heterogen
aetiolog
fraction
rang
bangladesh
kenya
less
zambia
gambia
mali
human
rhinoviru
predomin
kenya
explain
overrepresent
respiratori
infect
season
three
compar
two
season
african
site
appendix
basi
analysi
kenya
data
exclud
third
respiratori
season
data
shown
although
well
describ
caus
upper
respiratori
tract
infect
role
human
rhinoviru
caus
pneumonia
uncertain
possibl
human
rhinoviru
sever
respiratori
virus
might
incorrectli
attribut
true
caus
pneumonia
despit
methodolog
analyt
effort
address
gener
limit
extend
beyond
studi
casecontrol
studi
pneumonia
aetiolog
lead
exagger
contribut
virus
pneumonia
primari
specimen
use
assess
causal
upper
respiratori
tract
howev
signific
associ
wheez
data
shown
argu
bacteria
commonli
colonis
upper
respiratori
tract
pneumonia
h
influenza
inferenti
role
npop
pcr
estim
aetiolog
casecontrol
studi
inher
uncertainti
mitig
risk
underestim
attribut
aetiolog
bacteri
pathogen
analys
incor
porat
pathogen
densiti
measur
npop
specimen
distinguish
case
control
adjust
antibiot
exposur
lower
detect
npop
pcr
blood
pcr
pneumonia
addit
bacteri
pathogen
directli
sampl
lung
albeit
case
optimis
adjust
volum
blood
cultur
account
effect
previou
antibiot
exposur
sensit
bacteri
pathogen
detect
blood
cultur
account
low
sensit
blood
cultur
case
perch
studi
non
contamin
organ
isol
blood
cultur
pneumonia
common
isol
consist
childhood
pneumonia
aetiolog
studi
although
attempt
improv
identif
case
true
pneumococc
pneumonia
use
whole
blood
pcr
specif
poor
preval
similar
case
control
aor
improv
somewhat
bacteri
load
consid
aor
perhap
poor
specif
blood
pcr
due
low
level
seed
swallow
sputum
gastro
intestin
tract
absorpt
pneumococc
antigen
common
colonis
pneumonia
nasopharynx
mechan
also
believ
sourc
poor
pneumococc
urin
antigen
specif
despit
high
preval
pneumococc
npop
colonis
among
children
everi
site
preval
posit
blood
pcr
pneumonia
lower
asian
site
data
n
result
restrict
specimen
obtain
within
day
enrol
pathogen
determin
clinic
review
team
noncontamin
nanot
applic
total
number
case
posit
cultur
result
equal
number
organ
identifi
case
appear
multipl
row
posit
combin
pneumonia
lung
aspir
type
identifi
three
case
type
identifi
two
case
three
case
serotyp
avail
pcrposit
alon
pneumonia
pleural
fluid
type
identifi
one
case
four
case
serotyp
avail
posit
result
pcr
test
antigen
test
case
posit
h
influenza
lung
aspir
miss
serotyp
data
cultur
isol
neg
h
influenza
type
b
lung
aspir
pcr
case
posit
pneumonia
h
influenza
lung
aspir
cultur
posit
h
influenza
catarrhali
pneumonia
lung
aspir
pcr
therefor
report
twice
tabl
case
posit
pleural
fluid
pneumonia
antigen
test
two
also
posit
pneumonia
cultur
pcr
one
posit
pneumonia
antigen
test
asian
site
south
africa
site
posit
blood
cultur
pneumonia
unlik
four
african
site
investig
site
perform
blood
collect
cultur
found
methodolog
explan
inabl
isol
pneumonia
blood
cultur
three
site
lower
preval
posit
pneumococc
result
asian
site
compar
site
howev
south
africa
site
two
blood
cultur
sampl
alarm
posit
cultur
neg
pneumococci
chain
detect
gram
stain
binax
posit
three
site
isol
pneumococci
blood
patient
enrol
perch
studi
period
antibiot
treatment
specimen
collect
known
influenc
isol
bacteria
blood
np
previous
describ
substanti
influenc
pneumococc
detect
whole
blood
pcr
preval
antibiot
pretreat
particularli
high
zambia
south
africa
kenya
account
describ
previous
reduc
sensit
reason
expect
studi
would
lower
burden
pneumococc
diseas
earlier
studi
design
site
pcv
routin
use
target
particip
perch
studi
except
zambia
thailand
bangladesh
use
pcv
could
reduc
pneumococc
pneumonia
diseas
burden
approxim
site
serotyp
distribut
match
invas
pneumococc
diseas
low
pneumococc
aetiolog
attribut
support
low
preval
radiograph
consolid
shown
associ
bacteri
pneumonia
compris
perch
case
half
case
posit
chest
xray
furthermor
case
perch
studi
younger
year
mani
younger
month
group
often
exclud
analys
clinic
trial
pneumococc
vaccin
partli
form
basi
expect
pneumococc
burden
econom
develop
improv
access
care
might
also
reduc
hospit
admiss
pneumococc
pneumonia
effect
earli
outpati
treatment
site
thailand
absenc
detect
case
pneumococc
bacteraemia
might
simpli
reflect
low
enrol
number
given
invas
pneumococc
diseas
observ
site
studi
among
vaccineprevent
pathogen
tuberculosi
burden
vari
site
account
aetiolog
four
site
gambia
zambia
south
africa
thailand
less
elsewher
tuberculosi
rare
cultur
induc
sputum
gastric
aspir
south
africa
site
test
one
specimen
increas
yield
sensit
tuberculosi
cultur
low
test
pathogen
order
alphabet
among
bacteria
follow
virus
fungi
or
adjust
age
month
site
presenc
pathogen
detect
npop
pcr
adjust
previou
antibiot
use
known
influenc
bacteri
posit
preval
defin
use
npop
pcr
densiti
threshold
four
pathogen
pneumocysti
jirovecii
log
copi
per
ml
haemophilu
influenza
log
copi
per
ml
cytomegaloviru
log
copi
per
ml
streptococcu
pneumonia
log
copi
per
ml
npop
pcr
result
base
posit
appendix
pcvpneumococc
conjug
vaccin
singl
induc
sputum
specimen
remain
low
even
multipl
sampl
taken
children
pulmonari
tuberculosi
account
aetiolog
model
perhap
owe
high
vaccin
rate
b
pertussi
rare
identifi
present
often
found
children
younger
month
detect
b
pertussi
pcr
npop
specimen
highli
predict
case
statu
posit
identifi
control
saw
case
clinic
compat
measl
therefor
unlik
miss
mani
measlesrel
case
pneumonia
highlight
effort
measl
control
site
studi
hib
uncommon
caus
pneumonia
studi
less
com
mon
nontyp
b
h
influenza
longstand
use
hib
vaccin
sever
studi
site
could
account
low
contribut
hib
aetiolog
distribut
howev
two
site
contribut
hib
exceed
contribut
nonb
h
influenza
mali
zambia
lowest
hib
vaccin
rate
thailand
site
use
hib
vaccin
reason
small
contribut
hib
pneumonia
aetiolog
thailand
unclear
might
relat
access
outpati
antibiot
p
jirovecii
promin
caus
pneumonia
among
children
hiv
infect
perch
studi
shown
also
relev
caus
pneumonia
subset
children
without
hiv
infect
among
case
p
jirovecii
detect
npop
specimen
like
case
younger
month
malnourish
best
knowledg
singl
case
legionellosi
zambia
site
identifi
first
report
case
childhood
infect
due
l
longbeacha
africa
aetiolog
contribut
nontest
pathogen
ie
no
categori
approxim
site
analysi
sensit
analys
assum
higher
fraction
no
categori
aetiolog
prior
set
vs
conclud
no
categori
would
probabl
account
case
across
site
except
thailand
emphasis
strong
evid
exist
aetiolog
contribut
pathogen
test
studi
unless
substanti
confound
true
caus
pathogen
valu
chosen
aetiolog
prior
influenc
fraction
attribut
no
categori
analysi
use
estim
precis
size
no
categori
howev
line
repres
credibl
interv
darker
region
line
repres
iqr
size
symbol
scale
basi
ratio
estim
aetiolog
fraction
se
two
ident
aetiolog
fraction
estim
estim
associ
larger
symbol
inform
data
prior
posit
chest
xray
defin
consolid
infiltr
xray
follow
pathogen
contribut
less
aetiolog
fraction
overal
stratifi
age
sever
exclud
figur
coronaviru
chlamydophila
pneumonia
mycoplasma
pneumonia
streptococci
enterococci
includ
streptococcu
pyogen
enterococcu
faecium
nonfer
gramneg
rod
nfgnr
includ
acinetobact
spp
pseudomona
spp
enterobacteriacea
includ
escherichia
coli
enterobact
spp
klebsiella
spp
exclud
mix
gramneg
rod
pathogen
estim
subspeci
level
group
speci
level
display
includ
parainfluenza
viru
type
streptococcu
pneumonia
pcv
pneumonia
nonpcv
type
haemophilu
influenza
type
b
h
influenza
nontyp
b
influenza
b
c
exact
figur
includ
subspeci
serotyp
disaggreg
eg
type
type
given
appendix
nosnot
otherwis
specifi
ie
pathogen
test
affirm
no
account
small
fraction
pneumonia
caus
contribut
npop
data
assess
aetiolog
ical
probabl
depend
differ
frequenc
detect
case
control
valid
npop
infect
sourc
aetiolog
infer
select
group
pneumonia
pathogen
support
find
clear
distinct
preval
case
control
statu
found
consist
across
site
howev
npop
specimen
provid
littl
inferenti
valu
caus
pneumonia
individu
case
level
except
small
group
pathogen
rsv
b
pertussi
collect
induc
sputum
ad
littl
valu
beyond
npop
specimen
despit
high
qualiti
lower
respiratori
tract
specimen
pathogen
npop
lower
rule
u
h
f
r
ic
b
n
g
la
e
h
h
il
n
figur
sitespecif
aetiolog
result
ten
focu
pathogen
case
posit
chest
xray
without
hiv
infect
size
symbol
scale
basi
ratio
estim
aetiolog
fraction
se
two
ident
aetiolog
fraction
estim
estim
associ
larger
symbol
inform
data
prior
posit
chest
xray
defin
consolid
infiltr
xray
graph
restrict
ten
focu
pathogen
allsit
analysi
includ
aetiolog
estim
higher
higher
epidemiolog
interest
defin
treatabl
antibiot
pneumocysti
jirovecii
staphylococcu
aureu
avail
vaccin
influenza
viru
credibl
interv
aetiolog
fraction
three
pathogen
overlap
nonfocu
pathogen
henc
use
term
focu
pathogen
rather
label
ten
common
pathogen
pathogen
categori
repres
sum
aetiolog
fraction
remain
pathogen
test
present
figur
sitespecif
result
standardis
follow
case
mix
younger
year
sever
pneumonia
younger
year
sever
pneumonia
age
year
older
sever
pneumonia
age
year
older
sever
pneumonia
pathogen
estim
subspeci
level
group
speci
level
display
includ
parainfluenza
viru
type
streptococcu
pneumonia
pneumonia
type
haemophilu
influenza
type
b
h
influenza
nontyp
b
influenza
viru
b
c
exact
figur
given
appendix
nosnot
otherwis
specifi
ie
pathogen
test
summari
bacteria
exclud
mycobacterium
tuberculosi
role
causal
chain
possibl
studi
design
probe
longitudin
studi
design
need
better
understand
contribut
pathogen
pneumonia
aetiolog
better
explor
sequenc
npop
infect
lung
infect
despit
limit
npop
specimen
remain
substanti
import
pneumonia
aetiolog
studi
easili
collect
subject
molecular
diagnost
test
provid
valid
inform
infect
certain
pathogen
respiratori
tract
four
site
gambia
south
africa
mali
bangladesh
includ
lung
aspir
specimen
collect
part
studi
protocol
clinic
criteria
specimen
collect
ie
case
anterior
larg
rightsid
consolid
hesit
clinician
famili
delay
ethic
approv
train
site
case
radiograph
consolid
enrol
four
site
lung
aspir
specimen
collect
pathogen
detect
lung
aspir
lower
overal
cultur
pcr
undertaken
report
previou
studi
possibl
time
lung
aspir
occur
antibiot
administr
pleural
fluid
specimen
includ
studi
protocol
site
discret
treat
clinician
avail
case
least
one
standardis
chest
xray
reader
identifi
pleural
fluid
howev
pathogen
detect
specimen
bacteria
com
monli
detect
specimen
virus
common
pneumonia
lung
aspir
aureu
pleural
fluid
specimen
although
directli
reflect
true
caus
pneumonia
collect
highli
select
group
case
result
unlik
generalis
clinic
characterist
case
outcom
vari
substanti
site
high
variat
wheez
preval
among
case
especi
extrem
high
preval
bangladesh
might
relat
poor
air
qualiti
infect
underli
propens
bronchospasm
children
present
care
site
also
differ
mix
case
sever
might
reflect
underli
host
factor
eg
nutrit
statu
concurr
ill
eg
malaria
patient
propens
seek
care
abil
access
care
pathogen
find
differ
case
sever
possibl
stratif
case
finer
differ
defin
sever
indic
might
control
confound
site
casefat
ratio
vari
site
reflect
differ
case
sever
clinic
care
among
case
die
day
hospit
admiss
small
proport
death
occur
discharg
similar
proport
mortal
death
observ
occur
discharg
studi
sever
pneumonia
requir
hospit
admiss
children
younger
year
kilifi
contrast
substanti
proport
mortal
death
observ
occur
day
enrol
diarrhoeal
ill
gem
studi
although
children
follow
longer
period
obtain
chest
xray
small
proport
case
mani
death
soon
enrol
limit
represent
microbiolog
find
immedi
fatal
case
primari
analysi
among
case
chest
xray
either
normal
uninterpret
find
design
clinic
pneumonia
case
definit
highli
sensit
nonspecif
focus
epidemiolog
laboratori
characterist
case
pneumonia
posit
xray
enhanc
specif
clinic
case
definit
pneumonia
recognis
might
introduc
bia
exclud
gambia
rsv
pneu
case
pneumonia
whose
xray
find
lag
behind
clinic
find
case
lower
tract
diseas
caus
pathogen
chest
xray
infiltr
eg
pertussi
assess
bia
provid
analys
case
regardless
xray
find
observ
littl
differ
find
notabl
among
case
without
posit
chest
xray
either
miss
uninterpret
xray
perch
studi
period
site
obtain
reliabl
data
annual
season
pattern
increas
probabl
detect
pathogen
exhibit
multiyear
epidem
cycl
unlik
miss
season
outbreak
howev
pathogen
eg
b
pertussi
influenza
subtyp
parainfluenza
virus
mycoplasma
pneumonia
period
longer
month
therefor
might
observ
quiescent
period
among
ten
focu
pathogen
studi
subset
hmpv
parainfluenza
pneumonia
human
rhinoviru
h
influenza
tuberculosi
differ
impor
tanc
across
site
estim
contribut
pathogen
vari
age
strata
rsv
pertussi
parainflu
enza
type
p
jirovecii
aureu
pneumonia
parechovirusenteroviru
rhinoviru
diseas
sever
viral
caus
combin
rsv
aureu
pneumonia
parainfluenza
type
might
implic
treatment
guidelin
revis
prevent
measur
current
pathogen
increasingli
implement
proport
aetiolog
distribut
continu
chang
time
perch
studi
result
compar
childhood
pneumonia
aetiolog
studi
multisit
bostid
studi
import
histor
refer
detect
virus
bacteria
upper
respiratori
specimen
bacteri
antigen
urin
specimen
found
high
preval
rsv
pneumonia
hib
perch
studi
differ
substanti
bostid
studi
design
inclus
control
strict
standardis
case
definit
method
breadth
type
laboratori
test
multicountri
gabriel
pneumonia
casecontrol
aetiolog
studi
done
low
incom
set
publish
also
highlight
rsv
major
caus
pathogen
howev
aetiolog
attribut
rsv
substanti
lower
gabriel
studi
perch
studi
vs
discord
appear
mainli
attribut
differ
preval
rsv
gabriel
case
compar
perch
studi
case
rather
result
differ
analyt
approach
studi
design
methodolog
differ
probabl
affect
rate
rsv
detect
specif
age
distribut
case
enrol
gabriel
older
case
perch
gabriel
control
enrol
facil
rather
commun
although
pneumonia
detect
np
specimen
case
similar
two
studi
gabriel
vs
perch
detect
control
preval
consider
lower
gabriel
vs
result
high
attribut
fraction
gabriel
studi
differ
pneumococc
find
perch
gabriel
studi
unlik
lie
case
definit
use
similar
studi
instead
notabl
differ
exist
pcv
use
nearli
absent
gabriel
wide
use
perch
control
elig
facil
base
recruit
respiratori
symptom
gabriel
vs
commun
control
regardless
respi
ratori
symptom
casedefin
perch
addit
proport
case
control
detect
virus
bacteria
sub
stantial
higher
perch
case
control
mix
bacterialvir
detect
gabriel
case
control
suggest
differ
select
particip
clinic
laboratori
method
might
also
contribut
epic
studi
childhood
pneumonia
aetiolog
usa
rsv
human
rhinoviru
commonli
detect
pathogen
upper
respiratori
tract
among
young
children
hospitalis
radiograph
pneumonia
larger
proport
children
pathogen
detect
compar
perch
epic
vs
perch
south
african
drakenstein
case
control
substudi
pneumonia
aetiolog
use
multiplex
pcr
assay
perch
case
predominantli
children
nonsever
pneumonia
manag
outpati
set
median
age
month
nevertheless
rang
pathogen
similar
perch
studi
associ
pneumonia
case
statu
preval
influenza
higher
unlik
perch
studi
sever
pneumonia
hospit
admiss
drakenstein
substudi
found
cytomegaloviru
bocaviru
adenoviru
associ
case
statu
studi
sever
limit
particularli
relat
viral
pathogen
confound
pneumonia
aetiolog
copathogen
interpret
bacteri
aetiolog
descript
analysi
underscor
limit
inher
nearli
everi
pneumonia
aetiolog
studymultipl
specimen
multipl
test
vari
sensit
specif
absenc
establish
principl
method
integr
result
singl
aetiolog
analysisand
justifi
novel
analyt
approach
taken
casecontrol
studi
residu
confound
exclud
despit
match
control
commun
resid
age
season
case
like
factor
influenc
nasopharyng
infect
independ
influenc
infect
signific
lung
pathogen
eg
crowd
could
overestim
role
virus
underestim
role
bacteria
pia
model
integr
multipl
observ
laboratori
result
acknowledg
inher
error
laboratori
mea
urement
reduc
sensit
assay
previou
antibiot
use
low
blood
cultur
volum
indirect
natur
data
obtain
sampl
bodi
fluid
distant
lung
model
assum
case
primari
pathogen
caus
attempt
estim
whether
specif
pathogen
combin
necessari
pneumonia
approach
describ
detail
elsewher
contrast
standard
attribut
fraction
method
pia
model
includ
assumpt
sensit
laboratori
measur
aetiolog
prior
rang
provid
valid
assumpt
regard
sensit
limit
avail
data
diagnost
test
perform
despit
potenti
misspecif
assumpt
sensit
analys
show
aetiolog
result
robust
chang
valu
except
aetiolog
prior
no
furthermor
inher
abil
observ
studi
accur
defin
contribut
bacteria
pneumonia
uncertain
advanc
problem
requir
better
diagnost
discrimin
pcr
blood
sampl
pathogenspecif
infect
specif
biomark
specimen
npop
swab
lung
aspir
challeng
obtain
sampl
patient
antibiot
era
commun
case
manag
increasingli
unlik
vaccin
probe
studi
optim
way
reveal
contribut
pathogen
pneumonia
undertaken
one
two
pathogen
time
final
allsit
perch
studi
pneumonia
aetiolog
distribut
reflect
estim
distribut
case
pneumonia
admit
hospit
outsid
neonat
period
across
perch
studi
site
period
observ
recognis
pneumonia
import
ill
neonat
sister
studi
anisa
assess
caus
neonat
diseas
period
perch
studi
focus
children
outsid
neonat
period
result
perch
studi
extrapol
global
aetiolog
distribut
sever
childhood
pneumonia
interpret
aetio
logic
distribut
nation
level
particip
site
time
studi
initi
countri
elig
programm
gavi
vaccin
allianc
use
hib
vaccin
use
pcv
routin
immunis
programm
howev
perch
studi
intent
design
reflect
aetiolog
set
high
pcv
hib
vaccin
use
vaccin
expect
use
hib
vaccin
pcv
vaccin
gavielig
countri
furthermor
aetiolog
distribut
among
case
necessarili
reflect
aetiolog
distribut
among
pneumonia
death
especi
children
die
commun
without
provis
cur
care
effort
perch
studi
design
updat
evid
base
caus
seriou
pneumonia
use
advanc
clinic
microbiolog
analyt
method
deploy
across
geograph
epidemiolog
divers
studi
site
africa
south
asia
pneumonia
burden
greatest
beyond
compar
clinic
microbiolog
find
case
control
tradit
done
aetiolog
studi
use
novel
analyt
method
overcom
limit
tradit
approach
estim
aetiolog
distribut
cri
popul
individu
previous
infecti
aetiolog
studi
unabl
integr
result
multipl
specimen
type
multipl
pathogen
result
highlight
consist
pneumonia
aetiolog
find
across
site
diseas
sever
age
strata
provid
evid
target
hand
pathogen
consist
identifi
import
prevent
treatment
rsv
common
caus
seriou
pneumonia
hospit
admiss
set
target
dedic
prevent
treatment
effort
bacteri
pathogen
cumul
caus
substanti
proport
diseas
treatabl
commonli
fatal
remain
target
earli
access
appropri
support
cur
treatment
perch
studi
estim
pneumonia
requir
hospit
admiss
children
younger
year
without
hiv
infect
primari
viral
caus
howev
firmli
exclud
presenc
bacteri
co
infect
discuss
nevertheless
find
strengthen
need
adjust
pneumonia
treatment
algorithm
emphasis
support
care
identifi
children
antibiot
unlik
therapeut
therebi
reduc
pressur
anti
microbi
resist
futur
pneumonia
research
need
address
conundrum
multipl
pathogen
sequenc
role
pneumonia
pathogenesi
find
perch
studi
prompt
addit
invest
pneumonia
prevent
test
triag
treatment
encourag
use
innov
design
analys
aetiolog
studi
especi
assess
pneumonia
multipathogen
diseas
necessarili
repres
offici
posit
us
center
diseas
control
prevent
us
depart
health
human
servic
us
govern
